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tomography scans to identify not only the 
presence of BAT in adult humans, but 
also the possibility of inducing its meta-
bolic activity.[1–7] Consequently, increasing 
efforts have been dedicated to researching 
BAT as a possible therapeutic target in the 
treatment of metabolic diseases such as 
obesity or diabetes.[8,9]
Like white adipose tissue (WAT), BAT 
can store triglycerides, although its main 
function is to oxidize them and dissipate 
the resulting energy as heat in a pro-
cess called nonshivering thermogenesis. 
The biochemical reason for this activity 
is the high number of densely packed 
mitochondria in the brown adipocytes, 
together with the high expression of 
uncoupling protein 1 (UCP-1). Upon acti-
vation, UCP-1 acts as a proton channel 
within the inner mitochondrial mem-
brane, pumping back protons from the 
intermembrane space toward the mito-
chondrial matrix. This avoids adenosine 
triphosphate (ATP) synthase and thus dissipates the energy 
generated as heat.
The sympathetic nervous system is the main activator of BAT. 
When norepinephrine binds to the β3-adrenergic receptor, the 
levels of cyclic adenosine monophosphate (cAMP) increase, acti-
vating protein kinase A (PKA). This leads to increased lipolysis 
and the resulting fatty acids, which provide the fuel for mito-
chondrial β-oxidation[10] and are allosteric activators of UCP-1.[11] 
1. Introduction
Interest in the study of brown adipose tissue (BAT) has been 
reawakened in the past few years. Traditionally, the pres-
ence of this type of adipose tissue was considered residual 
in adult humans, and it was thought to be almost exclusively 
present in neonates. However, in 2009, several independent 
research groups used positron emission tomography-computed 
This is an open access article under the terms of the Creative Commons 
Attribution License, which permits use, distribution and reproduction in 
any medium, provided the original work is properly cited.
The rediscovery of brown adipose tissue (BAT) in humans and its capacity to 
oxidize fat and dissipate energy as heat has put the spotlight on its poten-
tial as a therapeutic target in the treatment of several metabolic conditions 
including obesity and diabetes. To date the measurement of bioenergetics 
parameters has required the use of cultured cells or extracted mitochondria 
with the corresponding loss of information in the tissue context. Herein, we 
present a method to quantify mitochondrial bioenergetics directly in BAT. 
Based on XF Seahorse Technology, we assessed the appropriate weight of the 
explants, the exact concentration of each inhibitor in the reaction, and the 
specific incubation time to optimize bioenergetics measurements. Our results 
show that BAT basal oxygen consumption is mostly due to proton leak. In 
addition, BAT presents higher basal oxygen consumption than white adipose 
tissue and a positive response to b-adrenergic stimulation. Considering the 
whole tissue and not just subcellular populations is a direct approach that 
provides a realistic view of physiological respiration. In addition, it can be 
adapted to analyze the effect of potential activators of thermogenesis, or to 
assess the use of fatty acids or glucose as a source of energy.
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Furthermore, PKA promotes the induction of UCP-1 expres-
sion through phosphorylation of p38 MAPK (mitogen-activated 
protein kinase) and cAMP-response-element-binding.[12,13]
In addition to sympathetic control, some novel BAT activa-
tors have been identified recently.[9,14] These include activa-
tors of nuclear hormone receptors, such as vitamin A-related 
mole cules or peroxisome proliferator-activated receptor (PPAR) 
inducers.[15,16] Other endocrine factors, such as cardiac natriu-
retic peptides,[17] irisin released from skeletal muscle,[18] or 
hepatic fibroblast growth factor-21,[19] have also been proposed 
to work as BAT activators.
Due to increased interest in the activation of this tissue, 
novel techniques to study BAT bioenergetics are required. The 
consumption of O2 in the mitochondria can be measured by 
several methods, including Clark-type oxygen electrodes,[20] the 
Oroboros Oxygraph-2k,[21] and fiber optic oxygen sensors.[22] 
However, the XF24 Extracellular Flux Analyzer (XF Seahorse 
Bioscience, North Billerica, MA) has several advantages. It can 
be used with small sample sizes, simultaneously detects the 
oxygen consumption rate (OCR) and the extracellular acidifi-
cation rate (ECAR) in 24-well or 96-well plates, and allows the 
use of replicates and multiple conditions. In addition, it avoids 
the mitochondrial rupture during the isolation process, one 
of the main disadvantages in the mitochondrial isolation pro-
tocols. Although the XF24 Extracellular Flux Analyzer method 
has been commonly used in isolated mitochondria and cul-
tured cells,[23,24] its application in tissue explants would provide 
deeper, clearer insight into physiological respiration.
In the present study, we show how to adapt the protocol 
using the XF24 Islet Capture Microplate in fresh explants of 
interscapular BAT (iBAT) from C57BL6/J mice, a common 
rodent model used in metabolic studies. Parameters such as 
the amount of tissue, the dosage of the inhibitors, and incu-
bation times were established to obtain more accurate results. 
This approach, which yields bioenergetic information about 
basal respiration, ATP turnover, proton leak, maximal respi-
ration, or spare respiratory capacity, provides a more accurate 
physiological overview of the respiratory status within the 
tissue than previous models using cultured cells or isolated 
mitochondria.
2. Results and Discussion
2.1. Ex Vivo Measurement of Cellular Bioenergetics Profile in 
Brown Adipose Tissue Explants
Several experiments were performed to titrate the key param-
eters and thus determine OCR in iBAT explants. Variables 
such as the number and weight of the explants, the concen-
tration of each inhibitor, and the reaction and incubation 
times were tested. Cutting the tissue in several pieces would 
provide an increased surface, improving the absorption of 
the inhibitors. However, the best results were achieved using 
9 mg of tissue in one single punch, since lower amounts often 
resulted in floating tissue inside the wells, leading to incor-
rect readings. We also established the optimal concentration of 
the inhibitors (24 µg mL−1 oligomycin, 0.8 × 10−6 m carbonyl 
cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), 5 × 10−6 m  
rotenone, 15 × 10−6 m antimycin A) and the stabilizing and 
injection times, which are described in Table 1.
Once the conditions had been established, we measured the 
OCR in iBAT from 13 C57BL6/J mice. The results are repre-
sented in Figure 1A, which shows the trace of the OCR over 
time and the effects of the different inhibitors. We first incu-
bated the tissue in assay media for 45 min prior to the analysis 
of the OCR. Once the OCR had stabilized, we programed five 
readings to record the basal respiration. Then, oligomycin (an 
ATP synthase inhibitor) was injected, to distinguish between 
respiration dedicated to the synthesis of ATP (referred to as 
ATP-linked respiration) and non-ATP linked consumption 
of oxygen. Typically, OCR decreases after oligomycin injec-
tion, depending on the degree of oxygen consumption used 
for ATP synthesis. It also induces respiratory state 4, causing 
an increase in the mitochondrial membrane potential (Δψm) 
and contributing to increased proton leak through the mem-
brane.[25,26] This may result in overestimation of the non-ATP 
linked OCR, but may only have a brief impact in the case of 
iBAT, which is already rich in uncoupling channels.
After FCCP addition, oxygen consumption is stimulated to 
reach the maximal OCR. With the addition of this uncoupling 
agent, the electron transport chain (ETC) is no longer con-
trolled by the proton gradient across the mitochondrial inner 
membrane. Finally, a mix of rotenone and antimycin A, both 
inhibitors of complexes in the electron transport chain, were 
added. Blocking the transport of electrons in the ETC leads 
to complete depletion of oxygen consumption in this chain, 
so the remaining oxygen consumption is preferentially due 
to extramitochondrial oxygenases or reactive oxygen species 
generation.
The raw data of the OCR obtained in this experiment are 
represented in Figure 1B. Our data have similar magnitudes 
to previous reports using the XF Seahorse technology in cul-
tured cells[27] or the Clark-type oxygen probe in BAT isolated 
mitochondria after tissue weight normalization.[28] Compared 
to previous observations in WAT,[29] iBAT shows a similar OCR 
corresponding to nonmitochondrial respiration, related mainly 
to the action of oxygenases.[30] Regarding mitochondrial respi-
ration, non-ATP-linked respiration was sevenfold higher than 
ATP-linked respiration, which reflects the high content of 
uncoupling proteins within the mitochondria of iBAT.
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Table 1. Seahorse XF24 run protocol.
Command Number of loops/cycles XF24 times [min]
Calibrate – –
Equilibrate Auto Auto
Mix, wait, measure 5 3, 2, 3
Inject A – –
Mix, wait, measure 4 3, 2, 3
Inject B – –
Mix, wait, measure 8 3, 2, 3
Inject C – –
Mix, wait, measure 5 3, 2, 3






2.2. Cellular Respiratory State Calculations Confirm Electron 
Transport Chain Uncoupling in Brown Adipose Tissue Explants
The cellular respiratory state in most cell mitochondria varies 
from state 3 (when both adenosine diphosphate (ADP)) and 
substrate levels are high, and consequently the respiration 
rate is also increased) and state 4 (when the respiration rate 
decreases due to low levels of ADP in spite of high levels of sub-
strate). This transition is modulated by changes in basal OCR, 
the coupling status, the maximal respiratory rate, or changes 
in the activation or levels of expression of proteins controlling 
respiration, among other factors. To calculate the apparent res-
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Where Basal represents the basal OCR, Oligo represents the 
OCR after oligomycin addition, and FCCP represents the FCCP-
stimulated OCR.[31] According to this formula, the apparent cell 
state in our model was 3.44, which suggest an intermediate res-
piration rate and ATP synthesis at the time of sacrifice.
In addition to the cellular respiratory state, the respiratory 
control rate (RCR), defined as the extent to which respiration 
is slowed down once the ADP has been completely phosphoryl-
ated, was defined as a gold standard for mitochondrial coupling. 
The bioenergetics profile can be used to calculate the RCR for 
oxidative phosphorylation by assuming that respiratory states 3 

















In our model, RCRbasal (Equation (2)) and RCRmax 
(Equation (3)) were 1.25 and 1.45, respectively. This indicates 
that the ETC and oxidative phosphorylation are highly uncou-
pled in our model, which is a typical characteristic of iBAT.
It is important to note that some of the potential applications 
of this method may require further normalization of the bio-
energetic data beyond controlling the tissue weight, as several 
metabolic conditions may involve different degrees of fat depo-
sition within the tissue. Here, we represent our results normal-
ized by protein content, but other parameters, such as relative 
mitochondrial DNA copy number may be used to normalize 
data.
2.3. Potential Applications of Bioenergetics Measurement in 
Brown Adipose Tissue
As an example of the potential applications of this method, 
we compared the basal OCR of iBAT from ten mice with their 
corresponding epididymal WAT (eWAT) (Figure 2A). Basal 
OCR in iBAT was increased compared to eWAT. This could be 
explained by increased ATP turnover within the cells, by nat-
ural differences in the proton leak because of the high expres-
sion of UCP-1 in iBAT, or by an increase in nonmitochondrial 
reactive oxygen species (ROS) production.[31] In addition, we 
tested our method to evaluate the iBAT respiration response to 
β-adrenergic stimulation. Norepinephrine was able to induce a 
twofold increase in BAT respiration (Figure 2B). This supports 
the application of our method to detect changes in respiration 
following BAT stimulation.
Future applications of this method may include the com-
parison of bioenergetics between different metabolic states, 
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Figure 1. Oxygen consumption rate in brown adipose tissue explants. 
9 mg of iBAT from 13 mice were analyzed using the XF24 Islet Capture 
Microplate. The amount of tissue, concentration of inhibitors, and incu-
bation times were used as described in the Experimental Section. The 
injection of inhibitors is represented as dashed lines. A) Average OCR 
trace, depicting basal oxygen consumption, oligomycin resistant respi-
ration (H+ leak), and ATP-linked OCR after the addition of 24 µg mL−1 
oligomycin. Maximal respiratory rate and reserve capacity were calculated 
after the injection of 0.8 × 10−6 m FCCP. Finally, 5 × 10−6 m rotenone and 
15 × 10−6 m antimycin A were added to observe nonmitochondrial respira-
tion. B) Bioenergetic parameters were inferred from the OCR traces. The 
results are represented as mean ± standard error of the mean (SEM). 
* Shows statistical differences between bioenergetic parameters and 
basal respiration. N = 13, p < 0.05.







treatment effects, or genetic models. The method can also be 
modified to investigate the impact of several effectors on iBAT 
activation by adding pretreatment steps to the tissue explants. 
Additionally, the fuel consumption of iBAT can be determined 
by coupling this detection method with the use of palmitate as 
a substrate. This allows the quantification of both endogenous 
and exogenous fatty acid oxidation. Finally, since glucose is also 
an important source of energy for this tissue,[32] the method can 
be adapted to determine glycolysis in real time, by detecting the 
ECAR.
3. Conclusion
We believe that this method improves bioenergetics measure-
ment for the following reasons: (1) the use of a whole tissue 
explant better reflects the physiological situation and avoids 
the mitochondrial isolation steps that commonly lead to mito-
chondrial rupture; (2) the use of a single punch of tissue 
avoids the misplacement of tissue in the plate, and thus leads 
to more accurate readings; (3) the concentration of the inhibi-
tors is adapted to the specific characteristics of iBAT and does 
not require previous permeabilization of the tissue; (4) a wide 
range of information can be retrieved by using simple adapta-
tions of this method (for example, bioenergetic parameters can 
be compared, and the influence of effectors or inhibitors on 
fuel utilization can be assessed).
This method can also be adapted for other tissues in animal 
or human models. Nonetheless, we recommend testing the 
proper normalizing parameter (weight of tissue, protein con-
tent, mitochondrial DNA) that best fits each specific situation.
4. Experimental Section
Preparation of the Sample: Eight-week-old male C57BL6/J mice 
were sacrificed by cervical dislocation after overnight fasting. All the 
procedures were performed in accordance with the University of 
Barcelona’s Ethical Committee for Animal Research.
iBAT and eWAT were excised and placed in small petri dishes containing 
wash media (eagle’s minimal essential medium (DMEM) (L0102-500, 
Biowest) supplemented with 25 × 10−3 m glucose and 25 × 10−3 m 
4-(2-hydroxyethyl)-1-piperazinemethanesulfonic acid (HEPES)). Hair and 
blood were removed by gentle agitation, and tissues were rerinsed in 
fresh wash media. 9 mg tissue samples were acquired using a scalpel 
from the same section of tissue. Tissues were kept in wash media until 
the respiration assay.
Application of Tissue to Assay Plate: The capture screens (Seahorse 
Bioscience, North Billerica, MA) were prewet in wash media in a small 
petri dish to remove any air bubbles. A pair of sterile forceps was used 
to position the screens (ring facing up), and a total of 9 mg of iBAT 
was placed on the screen with forceps. Then, the capture screen insert 
tool (Seahorse Bioscience, North Billerica, MA) was used to pick up the 
tissue-containing screens from the petri dish, and to place them in an 
XF24 Islet Capture Microplate (Seahorse Bioscience, North Billerica, 
MA). Once in position, all the tissues samples were rinsed twice with 
wash media, and once with assay media (AM, DMEM with 25 × 10−3 m 
glucose). Finally, 450 µL AM was added to all the samples and control 
wells.
Oxygen Consumption Rate Measurement: The Seahorse XF24 (Seahorse 
Bioscience, North Billerica, MA) was used to measure the OCR in 
real time. This system measures changes in oxygen concentration 
in a small amount of media that is isolated above the tissue. For a 
typical bioenergetic profile, a set of inhibitors (Sigma-Aldrich) of key 
components of cellular respiration were added. A range of concentrations 
of each compound was first tested until the optimal conditions 
were set: 8–24 µg mL−1 oligomycin, which blocks ATP synthase; 
0.8 × 10−6–24 × 10−6 m of the uncoupler FCCP; and a mix of rotenone 
(3 × 10−6–15 × 10−6 m) and antimycin A (3 × 10−6–12 × 10−6 m) 
as inhibitors of complexes I and III in the electron transport chain, 
respectively. To assess adrenergic stimulation, norepinephrine 
was also titrated using concentrations ranging from 
5 × 10−6 to 20 × 10−6 m.
The protocol is summarized in Table 1. Before the measurement, the 
microplate containing the tissues in AM was incubated at 37 °C without 
CO2 for 45 min. Then, the following final concentrations of the inhibitors 
were added after a set of titration experiments: 24 µg mL−1 oligomycin, 
0.8 × 10−6 m FCCP, 5 × 10−6 m rotenone, and 15 × 10−6 m antimycin A. All 
the dilutions were freshly prepared. The concentrations of the inhibitors 
added to each corresponding port in the microplate were ten times 
higher, to achieve the indicated final concentrations in the assay. Each 
OCR measurement consisted of 3 min of mixing, 2 min wait time, and 
3 min of continuous measuring of O2 levels. OCR was calculated by 
plotting the O2 tension of the media as a function of time (pmol min−1).
Calculations: Raw data output was transformed to OCR using 
the algorithm proposed by Gerencser et al.[33] Tissue bioenergetic 
parameters were calculated as follows. Basal OCR was normalized by 
subtracting the minimum rate after rotenone and antimycin A addition 
(which will be referred to as nonmitochondrial OCR). ATP-linked oxygen 
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Figure 2. Potential applications of bioenergetics measurement in brown 
adipose tissue. A) Comparative analysis of basal oxygen consumption in 
epididymal white adipose tissue (eWAT) and interscapular brown adipose 
tissue (iBAT). Basal OCR was analyzed in equal amounts of eWAT and 
iBAT, using the XF24 Islet Capture Microplate and normalized by mil-
ligrams of protein. B) OCR trace in iBAT explants after norepinephrine 
injection. The injection time and the concentrations used for the different 
compounds are shown. Rot: Rotenone. AA: Antimycin A. Results are rep-
resented as mean ± SEM. * Shows statistical differences between eWAT 
and iBAT. N = 13, p < 0.05.
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consumption was calculated as the difference between basal oxygen 
consumption and OCR, measured after the addition of oligomycin. 
Oligomycin resistant respiration (non-ATP-linked oxygen consumption 
or H+ leak) was calculated as the difference between the OCR obtained 
after the addition of oligomycin, minus nonmitochondrial OCR. Maximal 
OCR was determined by subtracting the nonmitochondrial OCR 
minimum reading from the maximal reading, following the addition 
of FCCP. Finally, the reserve capacity was calculated by subtracting the 
basal oxygen consumption rate from the maximal oxygen consumption 
after the addition of FCCP.
Statistical Analysis: Data were expressed as the mean ± SEM. 
Differences between the respiratory parameters compared to the basal 
OCR were analyzed using one-way analysis of variance, followed by 
posthoc Tukey’s multiple comparison tests. eWAT and iBAT basal OCR 
were compared using the Student’s t-test. p < 0.05 was considered 
statistically significant. All figures and statistical analyses were generated 
using GraphPad Prism 6 software.
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